Chapter PDF
References
Key references
Zerby AL III, Lee MJ, Brugge WR, Mueller PR: Endoscopic sonography of the upper gastrointestinal tract and pancreas. AJR Am J Roentgenol 1996, 166: 45–50.
Raptopoulos V, Steer ML, Sheiman RG, et al: The use of helical CT and CT angiography to predict vascular involvement from pancreatic cancer: correlation with findings at surgery. AJR Am J Roentgencol 1997, 168: 971–977.
Gattani AM, Mandeli J, Bruckner HW: Tumor markers in patients with pancreatic carcinoma. Cancer 1996, 78: 57–62.
Lehman GA, Uzer M: Pancreatic cancer. Curr Pract Med 1998, 4: 870–875.
van Riel JMGH, van Groeningen CJ, Pinedo HM, Giaccone G: Current chemotherapeutic possibilities in pancreaticobiliary cancer. Ann Oncol 1999, 10 (Suppl4): S157–S161.
Burns HA, Moore Mi, Andersen L, etal: Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 1997, 15: 2403–2413.
Howden ON, Woods BL: Self-expanding metal stents for palliative treatment of malignant biliary and duodenal stenoses. Gastromtest Endosc 1995, 42: 104–105.
Bradley EL III: A clinically based classification system for acute pancreatitis. Arch Surg 1993, 128: 586–590.
Brugge WR: Acute and chronic pancreatitis. Curr Pract Med 1998, 1: 861–867.
Poston GJ, Williamson RCN: Surgical management of acute pancreatitis. Br J Surg 1990, 77: 5–12.
Fernandez del Castillo C, Rattner DW, Warshaw AL: Acute pancreatitis. Lancet 1993, 342: 475–479.
Steinberg WM, et al: Controversies in clinical pancreatology. Pancreas 1996, 13: 219–225.
Steer ML, et al.: Chronic pancreatitis. N Engl J Med 1995, 332: 1482–1490.
Brugge WR: Acute and chronic pancreatitis, Curr PractMed 1998, 1: 861–867.
Ihse I, Permerth J: Enzyme therapy and pancreatic pain. Acta ChirScand 1990, 156: 281–283.
Ammann RW, et al: Course of alcoholic chronic pancreatitis. Gastroenterology 1996, 111: 224–231.
Malfertheiner P, Dominquez-Munoz JE, Büchler M: Diagnosis and staging of chronic pancreatitis. In Standards in Pancreatic Surgery. Edited by Beger HG, etal. Berlin: Springer-Verlag; 1993: 297–313.
Nealon WH, Thompson JC Progressive loss of pancreatic function in chronic pancreatitis is delayed by main pancreatic duct decompression. Ann Surg 1993, 217: 458–466.
Watanapa P, Williams RC: Pancreatic sphincterotomy and sphincteroplasty. Gut 1992, 33: 865–867.
Beger HG, Büchler M, Bittner R: The duodenum preserving resection of the head of the pancreas (DPRHP) in patients with chronic pancreatitis and an inflammatory mass in the head. Acta Chir Scand 1990, 156: 309–315.
Nesse RM, Bamurski MA: Anxiety disorders in primary care. In: Primary Care Psychiatry. Edited by Knespe DJ, Robi MB, Schwenk TL. Philadelphia: W.B. Saunders, 1997.
Boyer W: Serotonin uptake inhibitors are superior to imiprimine and alprazolam in alleviating panic attacks: a meta-analysis. Int Clin Psychopharmacol 1995, 10: 45–49.
Folles DG, Fuller WC: Anxiety disorders and insomnia in geriatric patients. Pychiatric Clin North Am 1997, 29 (1): 137–164.
Calne DB: Treatment of Parkinson’s disease. N Erigi J Med 1993, 329: 1021–1027.
Marsden CD: Parkinson’s disease. J Neurol Neurosurg Psychiatry 1994, 57: 672–681.
Anonymous: ICD-10 Classification of Mental and Behavioural Disorders. Clinical Descriptions and Diagnostic Guidelines. Geneva: World Health Organization; 1992.
Bronisch T, et al: The Munich diagnostic checklist for the assessment of DSM-III-R personality disorders for use in routine clinical care and research. Eur Arch Psychiatry Clin Neurosd 1992, 242: 77–81.
Stein G: Drug treatment of personality disorders. Br J Psychiatry 1992, 166: 67–84.
Speckens AM, et al.: Cognitive behavioural therapy for medically unexplained physical symptoms: a randomised controlled trail. BMJ 1995, 311: 1328–1332.
Mclsaac WJ, Gael V, Slaughter PM, etal: Reconsidering sore throats: problems with current clinical practice. Can Fain Physician 1997, 43: 485–493.
Carroll K, Reimer L: Microbiology and laboratory diagnosis of upper respiratory infections. Clin Infect Dis 1996, 23: 442–448.
Kline JA, Runge JW: Streptococcal pharyngitis: a review of pathophysiology, diagnosis, and management. J Emerg Med 1994, 12: 665–680.
Blumer JL, Goldfarb J: Meta-analysis in the evaluation of treatment for streptococcal pharyngitis: a review. Clin Ther 1994, 16: 604–620.
George JN, Shattil SJ: The clinical importance of acquired abnormalities of platelet function. N Engl J Med 1991, 324: 27–38.
George JN, Raskob GE: Idiopathic thrombocytopenic purpura: a concise summary of the pathophysiology and diagnosis in children and adults. Semin Hematol 1998, 35 (Suppl 1): 5–8.
Tarantino MD, Goldsmith G: Treatment of acute immune thrombocytopenic purpura. Semin Hematol 1998, 35 (Suppl 1): 28–35.
Blanchette V, Freedman J, Garvey B: Management of chronic immune thrombocytopenic purpura in children and adults. Semin Hematol 1998, 35 (Suppl 1): 36–51.
Bolan CD, Alving BM: Pharmacologic agents in the management of bleeding disorders. Transfusion 1990, 30: 541–551.
Kwaan HC, Soff GA: Management of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Semin Hematol 1997, 34: 159–166.
Collins TR, Sahn SA: Thoracentesis: complications, patient experience and diagnostic value. Chest 1987, 91: 817–819.
Bone R: The techniques of diagnostic and therapeutic thoracentesis. J Crit Illness 1990, 5: 371–379.
Light R, et al.: Pleural effusions: the diagnostic separation of transudates and exudates. Ann Intern Med 1972, 77: 507–513.
Keller SM: Current and future therapy for malignant pleural effusion. Chest 1993, 103 (suppi): 635–675.
Sahn S: Pleural effusion in lung cancer. Clin Chest Med 1993, 14: 189–200.
Light RW, Vargas FS: Pleural sclerosis for the treatment of pneumothorax and pleural effusion. Lung 1997, 175: 213–223.
Fine M, Smith D, Singer D: Hospitalization decision in patients with community- acquired pneumonia: a prospective study. Am J Med 1990, 89: 713–721.
Fang G, etal New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases. Medicine 1990, 69:307–316.
Bartlett JG, Mundy LM: Community- acquired pneumonia. N Engl J Med 1995, 333: 1618–1624.
Bartlett JG, Breiman RF Mandell LA, File TM Jr: Comrftunity-acquired pneumonia in adults: guidelines for management. Guidelines from the Infectious Disease Society of America. Clin Infect Dis 1998, 26: 811–838.
Niederman MS, et al: American Thoracic Society guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. Am Rev Respir Dis 1993, 148: 1418–1426.
Fine MJ, Smith MA, Carson CA, et al: Prognosis and outcome of patients with community-acquired pneumonia: a meta-analysis. JAMA 1996, 275: 134–141.
The choice of antibacterial drugs. Med Lett Drugs Ther 1999, 41 (1064): 95–104.
Fox R, et al: Oestrogen and androgen states in oligo-amenorrhoeic women with polycystic ovaries. Br J Obstet Gynaecol 1991, 98: 294–299.
Fox R, et al: Polycystic ovarian disease: diagnostic methods. Contemp Rev Obstet Gynaecol 1992, 4: 84–89.
Frank S: Polycystic ovary syndrome. N Engl J Med 1995, 333: 853–861.
Conway GS, et al.: Risk factors for coronary artery disease in lean and obese women with polycystic ovary syndrome, Clin Endocrinol 1992, 37: 119–125.
Jacobs HS: Polycystic ovary syndrome: aetiology and management. Curr Opm Obstet Gynecol 1995, 7: 203–208.
Lestico MR, et al.: Polymyalgia rheumatica. Clin Pharmacol 1993, 12: 571–580.
Chmelewsk» WL, et al: Presenting features and outcomes in patients undergoing temporal artery biopsy: a review of 98 patients. Arch Intern Med 1992, 152: 1690–1695.
Reech KA, et al: Neurologic manifestations of giant cell arteritis. Am J Med 1990, 89: 67–72.
Kyle Vf Cawston TE, Hazleman BL: Erythrocyte sedimentation rate and c reactive protein in the assessment of polymyalgia rheumatical giant cell arteritis on presentation and during follow-up. Ann Rheum Dis 1989, 48: 667–671.
Wilke WS, Hoffman GS: Treatment of corticosteroid resistant giant cell arteritis. Rheum Dis Clin North Am 1995, 21: 59–71.
Kyle V, Hazleman BL Treatment of polymyalgia rheumatica and giant cell arteritis. I. Steroid regimens in the first two months. Ann Rheum Dis 1989, 48: 658–661.
Krall PL, Mazanec Di, Wilke WS: Methotrexate for corticosteroid-resistant polymyalgia rheumatica and giant-cell arteritis. Cleve Clin J Med 1989, 56: 253–277.
Kyle V, Hazleman BL: Treatment of polymyalgia rheumatica and giant cell arteritis. II. Relation between steroid dose and steroid associated side effects. Ann Rheum Dis 1989, 48: 662 - 666.
Behn AR, Perera T, Myles AB: Polymyalgia rheumatica and corticosteroids: how much for how long? Ann Rheum Dis 1983, 42: 374–378.
Hunder GG: Giant cell arteritis and polymyalgia rheumatica. Med Clin North Am 1997, 81: 195–219.
Susman JL: Postpartum depressive disorders. J Fam Pract 1996, 43 (supp l): S17–S24.
O’Hara MW: Social support, life events and depression during pregnancy and the peurperium. Arch Gen Psych 1986, 43: 569–573.
Cooper Pi, etal.: Fortnightly review: postnatal depression. BMJ 1998, 316: 1884–1886.
Brawer MK: Prostate-specific antigen: current status. CA Cancer J Clin 1999, 49: 264–281.
Hahnfeld LE, Moon TD: Prostate cancer. Med Clin North Am 1999, 83: 1231–1245.
Gamick MB, Fair WR: Prostate cancer: emerging concepts (part 1). Ann Intern Med 1996, 125: 118–125.
Gamick MB, Fair WR: Prostate cancer: emerging concepts (part 2). Ann Intern Med 1996, 125: 205–212.
Henry RY, O’Mahony D: Treatment of prostate cancer. J Clin Pharm Ther 1999, 24: 93–102.
Sacher RA: Thrombophilia: a genetic predisposition to thrombosis. Trans Am Clin Climatol Assoc 1999, 110: 51–61.
Hirsch J, Weitz JL: New antithrombotic agents. Lancet 1999, 353: 1431–1436.
Lowe GDO: Risk of and prophylaxis for venous thromboembolism in hospital patients. BMJ 1992, 305: 567–574.
Raschke RA, Reilly BM, Guidry JR, et al: The weight-based heparin dosing nomogram compared with a “standard care” nomogram. Ann Intern Med 1993, 119: 874–881.
The Columbus Investigators: Low molecular weight heparin in the treatment of patients with venous thromboembolism. N Engl J Med 1997, 337: 657–662.
Poller L: Oral anticoagulation. J Clin Pathol 1990, 43: 177–183.
Bridges NA, Brook CDG; Premature sexual development. In Clinical Endocrinology. Edited by Grossman A. Oxford: Blackwell Scientific Publications; 1992: 837–846.
Stanhope R, Albanese A, Shalet S: Delayed puberty. BMJ 1992, 305: 790.
General references
Brown KE, Young NS: Parvovirus B19 in human disease. Am Rev Med 1997, 48: 59–67.
Gay Ni, etal: Age specific antibody prevalence to parvovirus B19: how many women are infected in pregnancy? Comm Dis Rep 1994, 4:R104–R107,
Levy R, Waissman A, Blomberg G, Hagay I: Infection by parvovirus B19 during pregnancy: a review. Obstet Gynecol Surv 1997, 52: 254–259.
Pattison JR: Human parvovirus B19. BMJ 1994, 308: 149–150.
Clifford CP, Davies GJ: Tuberculous pericarditis with rapid progression to constriction. BMJ 1993, 307: 1052–1054.
Sagrista-Sauleda J, et al: Long-term follow-up of idiopathic pericardial effusion. N Engl J Med 1999, 341: 2054–2059.
Ziskind AA, et al: Percutaneous balloon pericardiotomy for the treatment of cardiac tamponade and large pericardial effusions: description of technique and report of the first 50 cases. J Am Coll Cardiol 1993, 21: 1–5.
Armstrong JH, Barcia PJ: Pilonidal sinus disease: the conservative approach. Arch Surg 1994, 129: 914–918.
Barnett JL: Anorectal disease. In Textbook of Gastroenterology, edn 3. Edited by Yamada T. Philadelphia: Lippincott Williams & Wilkins; 1999: 2083–2106.
Sebastian MW: Pilonidal cysts and sinuses. In Textbook of Surgery, edn 15. Edited by Sabiston DC, Jr. Philadelphia: WB Saunders; 1996: 1330–1334.
Masur H: Prevention and treatment of Pneumocystis pneumonia. N Engl J Med 1992, 327: 1853–1860.
Moe AA, Hardy WD: Pneumocystis carinii infection in the HIV-seropositive patient. Infect Dis Clin North Am 1994, 8: 331–364.
Murray JF: Pulmonary complications of HIV infection. Am Rev Med 1996, 47: 117–126.
Santamauro JT, Stover DE: Pneumocystis carinii pneumonia. Med Clin North Am 81: 299–318.
Aurfíen D, et al.: The postpolio syndrome-a critical comment to the diagnosis. Acta Neurol Scand 1999, 100: 76–80.
Kid D, et al.: Late functional deterioration following paralytic poliomyelitis. QJM 1997, 90: 189–196.
Spector SA, et al: Strength gains without muscle injury after strength training in patients with postpolio muscular atrophy. Muscle Nerve 1996, 19: 1282–1290.
Thorsteinsson G: Management of postpolio syndrome. Mayo Clin Proc 1997, 72: 627–638.
Trojan DA, et al.: A multicenter, randomized, double-blinded trial of pyridostigmine in postpolio syndrome. Neurology 1999, 53: 1225–1233.
The post-polio syndrome: advances in the pathogenesis and treatment. Conference proceedings, ßethesda, Maryland, April 27–30, 1994. Ann NY Acad Sci 1995, 753:1–412.
Pressure Ulcers in Adults: Prediction and Prevention. Rockville: Agency for Health Care Policy and Research, Public Health Service, U.S. Department of Health and Human Services; 1992 [AHCPR Publication 92-0047.] (Available at U.S. National Library of Medicine’s Health Services; Technology Assessment Text (HSTAT) web page: http://text.nlm.nih.gov/). Pressure Ulcers in Adults: Treatment Rockville: Agency for Health Care Policy and Research, Public Health Service, U.S. Department of Health and Human Services; 1994. [AHCPR Publication 94-0075.]
Osterling J, Fuks Z, Lee CT, Scher HI: Cancer of the prostate. In Cancer: Principles and Practice of Oncology, edn 5. Edited by De Vita VT Jr, Hellman S, Rosenberg SA. Philadelphia: Lippincott-Raven; 1997: 1322–1386.
Thomas DP, Roberts HR: Hypercoagulability in venous and arterial thrombosis. Ann Intern Med 1997, 126: 638–644.
Denman ST: A review of pruritus. J Am Acad Dermatol 1986, 14: 375–392.
Giichrest B: Pruritus: pathogenesis, therapy, and significance in systemic disease states. Arch Intern Med 1982, 142: 101–105.
Greaves MW, Wall PD: Pathophysiology of itching. Lancet 1996, 348: 938–940.
Kam PCA, Tan KH: Pruritus—itching for a cause and relief? Anaesthesia 1996, 51: 1133–1138.
Millikan LE: Treating pruritus: what’s new in safe relief of symptoms. Postgrad Med 1996, 99: 173–184.
Yosipovitch G, David M: The diagnostic and therapeutic approach to idiopathic generalized pruritus. Int J Dermatol 1999, 38: 881–887.
Farber EM, Nail ML: The natural history of psoriasis in 5600 patients. Dermatologica 1974, 148: 1–18.
Greaves MW, Weinstein GD: Treatment of psoriasis. N Engl J Med 1995, 332: 581–588.
Highton A, Quell J: Calcipotreine ointment 0.005% for psoriasis: a safety and efficacy study. Calcipotreine study group. J Am Acad Dermatol 1995, 32: 67–72.
Koo J: Systemic sequential therapy of psoriasis: a new paradigm for improved therapeutic results. J Am Acad Dermatol 1999, 41 (3 Pt 2): S25–S28.
Nickoloff BJ: The immunologic and genetic basis of psoriasis. Arch Dermatol 1999, 135: 1104–1110.
Saurat JH: Retinoids and psoriasis: novel issues in retinoid pharmacology and implications for psoriasis treatment. J Am Acad Dermatol 1999, 41 (3 Pt 2): S2–S26.
Weinstein GD: Safety, efficacy and duration of therapeutic effect of tazarotene used in the treatment of plaque psoriasis. Br J Dermatol 1996, 135 (suppl 49): 32–36.
Zelickson BD, Muller SA: Generalized pustular psoriasis: a review of 63 cases. Arch Dermatol 1991, 127: 1339–1345.
Dichter JR, Levine SJF, Shelhamer JH: Approach to the immunocompromised host with pulmonary symptoms. Hematol Oncol Clin North Am 1993, 7: 887–912.
Lartholory O, Dupont B: Antifungal prophylaxis during neutropenia and immunodeficiency. Clin Microbiol Rev 1997, 10: 477–504.
Verra F, etai: Bronchoalveolar lavage in immunocompromised patients: clinical and functional consequences. Chest 1992, 101: 1215–1220.
Wade JC: Treatment of fungal and other opportunistic infections in immuno–compromised patients. Leukemia 1997, 11 (suppl 4): 5538–S539.
Carson JL, Kelley MA, Duff A, et al: The clinical course of pulmonary embolism. N Engl J Med 1992, 326: 1240–1245.
Goldhaber SZ: Pulmonary embolism. N Engl J Med 1998, 339: 93–104.
Abenhaim L, Moride Y, Brenot F, et al.: Appetite-suppressant drugs and the risk of primary pulmonary hypertension: International Primary Pulmonary Hypertension Study Group. N Engl J Med 1996, 335: 609–616.
D’Alonzo GE, Barst RJ, Ayres SM, et al: Survival in patients with primary pulmonary hypertension: results from a National Prospective Registry. Ann Intern Med 1991, 115: 343.
Rubin LJ: Primary pulmonary hypertension. N Engl J Med 1997, 336: 111–117.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media New York
About this chapter
Cite this chapter
Woolliscroft, J.O. (2001). P. In: Woolliscroft, J.O. (eds) Current Diagnosis & Treatment. Current Medicine Group, London. https://doi.org/10.1007/978-1-4684-0614-6_16
Download citation
DOI: https://doi.org/10.1007/978-1-4684-0614-6_16
Publisher Name: Current Medicine Group, London
Print ISBN: 978-1-57340-158-6
Online ISBN: 978-1-4684-0614-6
eBook Packages: Springer Book Archive